Cinolazepam
CAS: 75696-02-5
Category: Pharmaceutical Intermediates
| Purity | Research Grade ≥98.0%, High Purity Grade ≥99.0% |
| Molecular Formula | C20H16ClN3O2 |
| Molecular Weight | 365.82 |
| Appearance | White to off-white crystalline powder |
| Packaging | 1 kg aluminum foil bag with inner polyethylene liner, 5 kg sealed container, 25 kg fiber drum, or customized pharmaceutical-grade packaging |
| Testing Indicators | Appearance — Visual inspection; Identification — FTIR spectroscopy, 1H/13C NMR, and mass spectrometry (MS); Purity — HPLC analysis with UV detection; Molecular confirmation — LC-MS/HRMS; Melting point — Capillary method; Water content — Karl Fischer titration (ASTM E203); Residual solvents — GC analysis; Related substances — HPLC impurity profile analysis; Elemental analysis — CHN and chlorine determination; Heavy metals — ICP-OES/ICP-MS analysis when required. |
| Storage Notes | Store in a cool, dry, and well-ventilated warehouse. Keep containers tightly sealed and protected from moisture, heat, and direct sunlight. Avoid exposure to strong oxidizing agents, strong acids, and strong bases. For long-term storage, store under inert atmosphere and minimize repeated opening of containers. Handle with appropriate protective equipment. |
| Lead Time | 10 days |
Cinolazepam is a synthetic benzodiazepine derivative used primarily as a pharmaceutical research compound and analytical reference material. It is utilized in medicinal chemistry studies, benzodiazepine receptor research, pharmacological investigations, and analytical method development. It is supplied mainly for laboratory research, quality control, and reference standard applications.